Medical Journals

Evaluation of the Ability of Canarypox-vectored Equine Influenza Virus Vaccines to Induce Humoral Immune Responses Against Canine Influenza Viruses in Dogs.

Authors:
  • Karaca Kemal
  • Dubovi Edward J
  • Siger Leonardo
  • Robles Amy
  • Audonnet Jean-Christophe
  • Jiansheng Yao
  • Nordgren Robert
  • Minke Jules M

From: Merial Ltd, Research and Development Division, 115 Transtech Dr, Athens, GA 30601, USA.

American journal of veterinary research

  • Publish Date: Feb 2007
  • ISSN: 0002-9645
  • Volume: 68
  • Issue: 2
  • Pages: 208-12
  • Medium: Print
  • Language: English
  • Citation (JAMA): Karaca Kemal, Dubovi Edward J, Siger Leonardo, et al. Evaluation of the Ability of Canarypox-vectored Equine Influenza Virus Vaccines to Induce Humoral Immune Responses Against Canine Influenza Viruses in Dogs.. Am. J. Vet. Res. Feb 2007;68:208-12

Abstract

OBJECTIVE: To evaluate canarypox-vectored equine influenza virus (EIV) vaccines expressing hemagglutinins of A/equine/Kentucky/94 (vCP1529) and A2/equine/Ohio /03 (vCP2242) for induction of antibody responses against canine influenza virus (CIV) in dogs. ANIMALS: 35 dogs. PROCEDURES: Dogs were randomly allocated into 4 groups; group 1 (n = 8) and group 2 (9) were inoculated SC on days 0 and 28 with 1.0 mL (approx 10(5.7) TCID(50)) of vCP1529 and vCP2242, respectively. Dogs in group 3 (n = 9) were inoculated twice with 0.25 mL (approx 10(5.7) TCID(50)) of vCP2242 via the transdermal route. The 9 dogs of group 4 were control animals. All dogs were examined for adverse reactions. Sera, collected on days -1, 7, 13, 21, 28, 35, and 42, were tested by hemagglutination inhibition (HI) and virus neutralization (VN) assays for antibodies against CIV antigens A/Canine/FL/43/04-PR and A/Canine/NY/115809/05, respectively. RESULTS: Inoculations were tolerated well. The HI and VN antibodies were detected by 7 days after primary inoculation. Most dogs of groups 1 and 2 and all dogs of group 3 had detectable antibodies by 14 days after initial inoculation. The second inoculation induced an anamnestic response, yielding geometric mean HI titers of 139, 276, and 1,505 and VN titers of 335, 937, and 3,288 by day 42 (14 days after booster inoculation) in groups 1, 2, and 3, respectively. CONCLUSIONS AND CLINICAL RELEVANCE: Canarypox-vectored EIV vaccines induce biologically important antibodies and may substantially impact CIV transmission within a community and be of great value in protecting dogs against CIV-induced disease.

Mesh Headings (Keywords): Animals, Antibodies, Viral, Canarypox virus, Dog Diseases, Dogs, Female, Influenza A Virus, H3N8 Subtype, Influenza Vaccines, Male, Orthomyxoviridae Infections, Vaccines, Synthetic


Check for Full Text / PubMed Unique Identifier (PMID): 17269888


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.